Abbott Expanding Manufacturing Capacity in China

Abbott ABT announced today that it will invest $230 million (USD) to build a state-of-the-art nutrition manufacturing facility in Jiaxing, China. The facility represents Abbott's largest investment in China to date and will manufacture premium powdered milk products for Chinese infants and children.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!